Hormone Replacement Therapy Trial Halted Due to Cancer, Heart Risk
Read this tip to make your life smarter, better, faster and wiser. LifeTips is the place to go when you need to know about Women´s Health Tips and other Nurse topics.
Hormone Replacement Therapy Trial Halted Due to Cancer, Heart Risk
Researchers announced July 9, 2002 that they have halted one of the largest and best-designed studies of hormone replacement therapy because women taking the hormones after menopause had a greater risk of breast cancer, heart attack, stroke and blood clots than those who did not take the drugs.
More than 6 million women in the US currently take estrogen/progestin hormone combination therapy for a variety of reasons, including cures of hot flashes and other menopausal symptoms. The hope--and the hype--has been that such hormones would also confer a number of other advantages, including a reduced risk of heart disease. The study suggests that when women take the drugs for more than about 5 years, the risks of the hormones clearly outweigh the benefits.
